官方服务：
资源简介：
Summary of all cases for case series on dupilumab exposure during pregnancy
应用场景：
相关数据集
Safety of dermatologic medications in pregnancy and lactation: An Update - Part I: Pregnancy
Supplemental Table 1: International Grading Classifications for Pregnancy and Lactation
Mendeley Data2024-03-27 更新50
Statistically significant results obtained using SICK or OECA approaches.
References: (1): (M→BD) is the risk that the study medication (“M”) causes the birth defect studied (“BD”); (2): (M→OBD) is the risk that the study medication (“M”) produces congenital anomalies other
NIAID Data Ecosystem10
Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth
BackgroundThe associations of individual antiepileptic drugs (AEDs) with pregnancy duration and size at birth, and potential dose relations, are not well characterized.MethodsThis cohort study used na
Figshare2019-08-05 更新10
Medications and pregnancy: The role of community pharmacists – A descriptive study
BackgroundSafe use of medications during pregnancy requires a comprehensive understanding of risk-benefit profiles for individual treatments. Pharmacists are supported in this aspect by clinical infor
Figshare2018-05-09 更新40
Maternal outcomes in matched population.
PurposeThis retrospective cohort study aimed to evaluate the effects and adverse outcomes of continuous and repeated treatment with atosiban in twin pregnancies with threatened preterm labor.Patients
Figshare2025-07-09 更新10
